174 related articles for article (PubMed ID: 11996696)
1. Emergence of vancomycin-intermediate Staphylococcus aureus and S. sciuri, Greece.
Tsakris A; Papadimitriou E; Douboyas J; Stylianopoulou F; Manolis E
Emerg Infect Dis; 2002 May; 8(5):536-7. PubMed ID: 11996696
[No Abstract] [Full Text] [Related]
2. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
[No Abstract] [Full Text] [Related]
3. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
[No Abstract] [Full Text] [Related]
5. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
6. [Use of glycopeptides in the treatment of infections caused by methicillin-resistant staphylococci].
Bouza E; Rodríguez-Créixems M; Muñoz P
Rev Clin Esp; 1997 Sep; 197 Suppl 2():52-8. PubMed ID: 9441324
[No Abstract] [Full Text] [Related]
7. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
8. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases.
Arda B; Yamazhan T; Sipahi OR; Islekel S; Buke C; Ulusoy S
Int J Antimicrob Agents; 2005 May; 25(5):414-8. PubMed ID: 15848297
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin.
Ma XX; Wang EH; Liu Y; Luo EJ
J Med Microbiol; 2011 Nov; 60(Pt 11):1661-1668. PubMed ID: 21799199
[TBL] [Abstract][Full Text] [Related]
10. Glycopeptide resistance in Staphylococcus aureus.
Chadwick PR; Wooster SL
J Infect; 2000 May; 40(3):211-7. PubMed ID: 10908014
[No Abstract] [Full Text] [Related]
11. [Antibiotic sensitivity of S. aureus strains isolated from meningeal infections].
Fedulov D; Mihalache DG
Bacteriol Virusol Parazitol Epidemiol; 2007; 52(3-4):125-8. PubMed ID: 19326725
[No Abstract] [Full Text] [Related]
12. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
Nashev D; Toshkova K; Gavrilova V
Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
[TBL] [Abstract][Full Text] [Related]
13. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
Rebiahi SA; Abdelouahid DE; Rahmoun M; Abdelali S; Azzaoui H
Med Mal Infect; 2011 Dec; 41(12):646-51. PubMed ID: 22033230
[TBL] [Abstract][Full Text] [Related]
14. Glycopeptide resistance in Staphylococcus haemolyticus during treatment with teicoplanin.
Blans M; Troelstra A
Infect Control Hosp Epidemiol; 2001 May; 22(5):263-4. PubMed ID: 11428432
[No Abstract] [Full Text] [Related]
15. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
[TBL] [Abstract][Full Text] [Related]
16. Detecting vancomycin intermediate Staphylococcus aureus.
Commun Dis Rep CDR Wkly; 1997 Nov; 7(47):417, 20. PubMed ID: 9401190
[No Abstract] [Full Text] [Related]
17. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
Adra M; Lawrence KR
Ann Pharmacother; 2004 Feb; 38(2):338-41. PubMed ID: 14742775
[TBL] [Abstract][Full Text] [Related]
18. Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
Mariani PG; Sader HS; Jones RN
J Antimicrob Chemother; 2006 Aug; 58(2):481-3. PubMed ID: 16847029
[No Abstract] [Full Text] [Related]
19. [Staphylococcal infection in the newborn: teicoplanin therapy].
Fanos V; Khoory BJ; Danieli D; Padovani EM
Pediatr Med Chir; 1993; 15(6):579-82. PubMed ID: 8197017
[TBL] [Abstract][Full Text] [Related]
20. Selection of resistance to glycopeptide antibiotics in staphylococci.
Biavasco F; Giovanetti E; Varaldo PE
J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
